HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Breast Cancer Update
00:00
When is T-DXd rechallenge appropriate after ILD?
Dr Huppert explains considerations for re‑challenging after grade 1 ILD, caution for grade ≥2, and ambiguous infectious scenarios.
Play episode from 08:45
Transcript
